{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:15:03Z","timestamp":1772165703661,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:00:00Z","timestamp":1583971200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:00:00Z","timestamp":1583971200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Huntington\u2019s disease (HD), an inherited, often late-onset, neurodegenerative disorder, is considered to be a rare, orphan disease. Research into its genetic correlates and services for those affected are inadequate in most low-middle income countries, including India. The apparent \u2018incurability\u2019 often deters symptomatic and rehabilitative care, resulting in poor quality of life and sub-optimal outcomes. There are no studies assessing disease burden and outcomes from India.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We attempted to evaluate individuals diagnosed to have HD at our tertiary-care center between 2013 and 2016 for clinical symptoms, functionality, mortality, follow up status through a structured interview, clinical data from medical records and UHDRS-TFC scoring.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the 144 patients, 25% were untraceable, and another 17 (11.8%) had already died. Mean age at death and duration of illness at the time of death, were 53\u2009years and 7\u2009years respectively, perhaps due to suicides and other comorbidities at an early age. The patients who could be contacted (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200981) were assessed for morbidity and total functional capacity (TFC). Mean CAG repeat length and TFC score were 44.2 and 7.5 respectively. Most individuals (66%) were in TFC stage I and II and could perhaps benefit from several interventions. The TFC score correlated inversely with duration of illness (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001). The majority were being taken care of at home, irrespective of the physical and mental disability. There was a high prevalence of psychiatric morbidity (91%) including suicidal tendency (22%). Three of the 17 who died had committed suicide, and several other families reported suicidal history in other family members. Only about half the patients (57%) maintained a regular clinical follow-up.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study demonstrates the poor follow-up rates, significant suicidality and other psychiatric symptoms, sub-optimal survival durations and functional outcomes highlighting the need for holistic care for the majority who appear to be amenable to interventions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-020-01671-x","type":"journal-article","created":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T09:03:08Z","timestamp":1584003788000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Psychiatric morbidity and poor follow-up underlie suboptimal functional and survival outcomes in Huntington\u2019s disease"],"prefix":"10.1186","volume":"20","author":[{"given":"Nikhil","family":"Ratna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitish L.","family":"Kamble","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sowmya D.","family":"Venkatesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meera","family":"Purushottam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pramod K.","family":"Pal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjeev","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,12]]},"reference":[{"issue":"6","key":"1671_CR1","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"ME MacDonald","year":"1993","unstructured":"MacDonald ME, Ambrose CM, Duyao MP, Myers RH, Lin C, Srinidhi L, et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell. 1993;72(6):971\u201383.","journal-title":"Cell."},{"issue":"4","key":"1671_CR2","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","volume":"10","author":"CA Ross","year":"2014","unstructured":"Ross CA, Aylward EH, Wild EJ, Langbehn DR, Long JD, Warner JH, et al. Huntington disease: natural history, biomarkers and prospects for therapeutics. Nat Rev Neurol. 2014;10(4):204\u201316. https:\/\/doi.org\/10.1038\/nrneurol.2014.24.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"1671_CR3","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1750-1172-5-40","volume":"5","author":"RA Roos","year":"2010","unstructured":"Roos RA. Huntington's disease: a clinical review. Orphan J Rare Dis. 2010;5(1):40.","journal-title":"Orphan J Rare Dis"},{"issue":"10","key":"1671_CR4","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1073\/pnas.0308679101","volume":"101","author":"NS Wexler","year":"2004","unstructured":"Wexler NS. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proc Natl Acad Sci. 2004;101(10):3498\u2013503.","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"1671_CR5","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.cell.2015.07.003","volume":"162","author":"J-M Lee","year":"2015","unstructured":"Lee J-M, Wheeler VC, Chao MJ, Vonsattel JPG, Pinto RM, Lucente D, et al. Identification of genetic factors that modify clinical onset of Huntington\u2019s disease. Cell. 2015;162(3):516\u201326.","journal-title":"Cell."},{"issue":"2","key":"1671_CR6","doi-asserted-by":"publisher","first-page":"e29522","DOI":"10.1371\/journal.pone.0029522","volume":"7","author":"ER Dorsey","year":"2012","unstructured":"Dorsey ER, Investigators HSGC. Characterization of a large group of individuals with Huntington disease and their relatives enrolled in the COHORT study. PloS One. 2012;7(2):e29522.","journal-title":"PloS One"},{"issue":"13","key":"1671_CR7","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.4103\/0366-6999.159359","volume":"128","author":"M Xu","year":"2015","unstructured":"Xu M, Wu Z-Y. Huntington disease in Asia. Chin Med J. 2015;128(13):1815.","journal-title":"Chin Med J"},{"issue":"1\u20132","key":"1671_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0022-510X(01)00593-7","volume":"190","author":"UA Murgod","year":"2001","unstructured":"Murgod UA, Saleem Q, Anand A, Brahmachari S, Jain S, Muthane UB. A clinical study of patients with genetically confirmed Huntington's disease from India. J Neurol Sci. 2001;190(1\u20132):73\u20138.","journal-title":"J Neurol Sci"},{"issue":"4","key":"1671_CR9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1034\/j.1600-0404.2003.00133.x","volume":"108","author":"Q Saleem","year":"2003","unstructured":"Saleem Q, Roy S, Murgood U, Saxena R, Verma I, Anand A, et al. Molecular analysis of Huntington's disease and linked polymorphisms in the Indian population. Acta Neurol Scand. 2003;108(4):281\u20136.","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"1671_CR10","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s40291-018-0327-y","volume":"22","author":"P Chheda","year":"2018","unstructured":"Chheda P, Chanekar M, Salunkhe Y, Dama T, Pais A, Pande S, et al. A study of triplet-primed PCR for identification of CAG repeat expansion in the HTT gene in a cohort of 503 Indian cases with Huntington\u2019s disease symptoms. Mol Diag Ther. 2018;22(3):353\u20139.","journal-title":"Mol Diag Ther"},{"issue":"141","key":"1671_CR11","first-page":"2161","volume":"4","author":"J Sheth","year":"2015","unstructured":"Sheth J, Shah S, Patel H, Bhavsar R, Bhatt K, Sheth F. A study on triplet repeat expansion disorders in Western Indian population. Hereditary Genet. 2015;4(141):2161\u20131041.1000141.","journal-title":"Hereditary Genet"},{"issue":"4","key":"1671_CR12","first-page":"156","volume":"29","author":"P Chhuttani","year":"1957","unstructured":"Chhuttani P. Huntington's chorea in India. J Indian Med Assoc. 1957;29(4):156\u20137.","journal-title":"J Indian Med Assoc"},{"issue":"4","key":"1671_CR13","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3233\/JHD-150166","volume":"4","author":"A Lenka","year":"2015","unstructured":"Lenka A, Kamble NL, Sowmya V, Jhunjhunwala K, Yadav R, Netravathi M, et al. Determinants of onset of Huntington\u2019s disease with behavioral symptoms: insight from 92 patients. J Huntington\u2019s Dis. 2015;4(4):319\u201324.","journal-title":"J Huntington\u2019s Dis"},{"key":"1671_CR14","volume-title":"I6 Trinucleotide repeats and haplotypes at the huntingtin locus in an Indian sample overlaps with European Haplogroup A. In., 1 edn: PLOS Currents Huntington Disease","author":"NS Moily","year":"2014","unstructured":"Moily NS, Kota LN, Anjanappa RM, Venugopal S, Vaidyanathan R, Pal P, et al.: I6 Trinucleotide repeats and haplotypes at the huntingtin locus in an Indian sample overlaps with European Haplogroup A. In., 1 edn: PLOS Currents Huntington Disease; 2014."},{"key":"1671_CR15","doi-asserted-by":"publisher","unstructured":"Unified Huntington's disease rating scale: Reliability and consistency. Movement Disorders. 1996;11 2:136\u201342; doi: https:\/\/doi.org\/10.1002\/mds.870110204..","DOI":"10.1002\/mds.870110204"},{"issue":"1","key":"1671_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/wnl.29.1.1","volume":"29","author":"I Shoulson","year":"1979","unstructured":"Shoulson I, Fahn S. Huntington disease: Clinical care and evaluation. Neurology. 1979;29(1):1. https:\/\/doi.org\/10.1212\/wnl.29.1.1.","journal-title":"Neurology"},{"issue":"2","key":"1671_CR17","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1159\/000443738","volume":"46","author":"MD Rawlins","year":"2016","unstructured":"Rawlins MD, Wexler NS, Wexler AR, Tabrizi SJ, Douglas I, Evans SJ, et al. The prevalence of Huntington's disease. Neuroepidemiology. 2016;46(2):144\u201353.","journal-title":"Neuroepidemiology."},{"issue":"5","key":"1671_CR18","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1002\/mdc3.12502","volume":"4","author":"FB Rodrigues","year":"2017","unstructured":"Rodrigues FB, Abreu D, Dam\u00e1sio J, Goncalves N, Correia-Guedes L, Coelho M, et al. Survival, mortality, causes and places of death in a European Huntington's disease prospective cohort. Movement Dis Clin Pract. 2017;4(5):737\u201342.","journal-title":"Movement Dis Clin Pract"},{"issue":"6","key":"1671_CR19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3390\/brainsci7060067","volume":"7","author":"RA Paoli","year":"2017","unstructured":"Paoli RA, Botturi A, Ciammola A, Silani V, Prunas C, Lucchiari C, et al. Neuropsychiatric burden in Huntington\u2019s disease. Brain Sci. 2017;7(6):67.","journal-title":"Brain Sci"},{"issue":"3","key":"1671_CR20","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.psychres.2011.05.006","volume":"188","author":"HH Wetzel","year":"2011","unstructured":"Wetzel HH, Gehl CR, Dellefave-Castillo L, Schiffman JF, Shannon KM, Paulsen JS, et al. Suicidal ideation in Huntington disease: the role of comorbidity. Psychiatry Res. 2011;188(3):372\u20136.","journal-title":"Psychiatry Res"},{"issue":"1","key":"1671_CR21","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.jad.2013.06.001","volume":"151","author":"AA Hubers","year":"2013","unstructured":"Hubers AA, van Duijn E, Roos RA, Craufurd D, Rickards H, Landwehrmeyer GB, et al. Suicidal ideation in a European Huntington's disease population. J Affect Disord. 2013;151(1):248\u201358.","journal-title":"J Affect Disord"},{"issue":"4","key":"1671_CR22","doi-asserted-by":"publisher","first-page":"304","DOI":"10.4103\/0019-5545.104793","volume":"54","author":"R Radhakrishnan","year":"2012","unstructured":"Radhakrishnan R, Andrade C. Suicide: an Indian perspective. Indian J Psychiatry. 2012;54(4):304.","journal-title":"Indian J Psychiatry"},{"issue":"11","key":"1671_CR23","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1007\/s00415-018-9013-6","volume":"265","author":"P Honrath","year":"2018","unstructured":"Honrath P, Dogan I, Wudarczyk O, G\u00f6rlich KS, Votinov M, Werner CJ, et al. Risk factors of suicidal ideation in Huntington\u2019s disease: literature review and data from enroll-HD. J Neurol. 2018;265(11):2548\u201361.","journal-title":"J Neurol"},{"issue":"12","key":"1671_CR24","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1136\/jnnp-2013-307343","volume":"85","author":"E van Duijn","year":"2014","unstructured":"van Duijn E, Craufurd D, Hubers AA, Giltay EJ, Bonelli R, Rickards H, et al. Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY). J Neurol Neurosurg Psychiatry. 2014;85(12):1411\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"1671_CR25","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1136\/jnnp.71.3.310","volume":"71","author":"JS Paulsen","year":"2001","unstructured":"Paulsen JS, Ready R, Hamilton J, Mega M, Cummings J. Neuropsychiatric aspects of Huntington's disease. J Neurol Neurosurg Psychiatry. 2001;71(3):310\u20134.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"1671_CR26","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1176\/jnp.2009.21.3.266","volume":"21","author":"P Naarding","year":"2009","unstructured":"Naarding P, Janzing JG, Eling P, van der Werf S, Kremer B. Apathy is not depression in Huntington\u2019s disease. J Neuropsychiatry Clin Neurosci. 2009;21(3):266\u201370.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"2","key":"1671_CR27","first-page":"149","volume":"40","author":"VM Reddy","year":"1998","unstructured":"Reddy VM, Chandrashekar C. Prevalence of mental and behavioural disorders in India: A meta-analysis. Indian J Psychiatry. 1998;40(2):149.","journal-title":"Indian J Psychiatry"},{"issue":"9","key":"1671_CR28","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1002\/mds.22953","volume":"25","author":"GM Peavy","year":"2010","unstructured":"Peavy GM, Jacobson MW, Goldstein JL, Hamilton JM, Kane A, Gamst AC, et al. Cognitive and functional decline in Huntington's disease: dementia criteria revisited. Mov Disord. 2010;25(9):1163\u20139.","journal-title":"Mov Disord"},{"issue":"4","key":"1671_CR29","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1044\/sasd21.4.126","volume":"21","author":"C Stewart","year":"2012","unstructured":"Stewart C. Dysphagia symptoms and treatment in Huntington's disease. Perspectives Swallowing and Swallowing Disorders (Dysphagia). 2012;21(4):126\u201334.","journal-title":"Perspectives Swallowing and Swallowing Disorders (Dysphagia)"},{"issue":"2","key":"1671_CR30","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1212\/WNL.54.2.452","volume":"54","author":"K Marder","year":"2000","unstructured":"Marder K, Zhao H, Myers R, Cudkowicz M, Kayson E, Kieburtz K, et al. Rate of functional decline in Huntington\u2019s disease. Neurology. 2000;54(2):452.","journal-title":"Neurology"},{"issue":"2","key":"1671_CR31","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3233\/JHD-160192","volume":"5","author":"JC Frich","year":"2016","unstructured":"Frich JC, Rae D, Roxburgh R, Miedzybrodzka ZH, Edmondson M, Pope EB, et al. Health care delivery practices in Huntington\u2019s disease specialty clinics: an international survey. J Huntington's Dis. 2016;5(2):207\u201313.","journal-title":"J Huntington's Dis"},{"issue":"3","key":"1671_CR32","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/j.1365-2648.2009.05217.x","volume":"66","author":"H Skirton","year":"2010","unstructured":"Skirton H, Williams JK, Jackson Barnette J, Paulsen JS. Huntington disease: families\u2019 experiences of healthcare services. J Adv Nurs. 2010;66(3):500\u201310.","journal-title":"J Adv Nurs"},{"key":"1671_CR33","doi-asserted-by":"publisher","first-page":"710","DOI":"10.3389\/fneur.2019.00710","volume":"10","author":"A-C Bachoud-L\u00e9vi","year":"2019","unstructured":"Bachoud-L\u00e9vi A-C, Ferreira J, Massart R, Youssov K, Rosser A, Busse M, et al. International Guidelines for the treatment of Huntington\u2019s Disease. Front Neurology. 2019;10:710.","journal-title":"Front Neurology"},{"key":"1671_CR34","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3389\/fneur.2019.00453","volume":"10","author":"S Migliore","year":"2019","unstructured":"Migliore S, Jankovic J, Squitieri F. Genetic counseling in Huntington's disease: potential new challenges on horizon? Front Neurol. 2019;10:453.","journal-title":"Front Neurol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-020-01671-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-020-01671-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-020-01671-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T19:32:55Z","timestamp":1615491175000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-020-01671-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,12]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1671"],"URL":"https:\/\/doi.org\/10.1186\/s12883-020-01671-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.10368\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.10368\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.10368\/v3","asserted-by":"object"}]},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,12]]},"assertion":[{"value":"23 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study is an audit of a part of PhD thesis dissertation approved by Ethics Committee (Ref No. NIMH\/DO\/ETHICS SUB-COMMITTEE 29th MEETING\/2016) of National Institute of Mental Health and Neurosciences (NIMHANS). Written consent has been taken from people under regular follow-up and verbal consent was obtained during telephonic interviews for those who are not under follow-up or are not alive. Informants\/patients were explained about the survey in the very beginning and given a choice to participate or decline before continuing with the interview. This has been approved by the committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"87"}}